Pharmaceutical API Manufacturing Market Opportunities And Strategies To 2032

Pharmaceutical API Manufacturing Market 2023 – By Therapy Area (Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Musculoskeletal Disorders, Other Therapeutics Uses), By API Type (Chemical API, Biological API), By Drug Type (Prescription Drugs, Over The Counter Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2032

Starting Price : $5000.00 | Pages : 296 | Published : January 2023 | | Format : pdf

Purchase Options
Request Sample
Request For Discount

Need assistance or more information before the purchase?

Enquire Before Buying
Pharmaceutical API Manufacturing Global Market Opportunities And Strategies To 2032

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Pharmaceutical API Manufacturing Market Definition

The active pharmaceutical ingredients (API) manufacturing market consists of sales of pharmaceutical active pharmaceutical ingredients and related services. Active pharmaceutical ingredients are used to produce drugs which treat various diseases such as cardiovascular diseases, rare genetic disorders, infections, metabolic disorders, cancers, respiratory diseases and others. Active pharmaceutical ingredients are the chemical which is responsible for the pharmacological activity in the living body and are used as a major base for preparation of drugs.

Pharmaceutical API Manufacturing Market Size

The pharmaceutical API manufacturing market size reached a value of nearly $184,949.84 million in 2021, having grown at a compound annual growth rate (CAGR) of 5.08% since 2016. The market is expected to grow from $184,949.84 million in 2021 to $248,026.93 million in 2026 at a rate of 6.04%. The pharmaceutical API manufacturing market size is then expected to grow at a CAGR of 5.89% from 2026 and reach $330,161.93 million in 2031.    

Growth in the historic period resulted from an increase in pharmaceutical R&D expenditure, increasing preference for outsourcing APIs, growing prevalence of chronic illness, increased healthcare expenditure, a rise in disposable income, an increase in patent expiration and growing government policies for API production. Factors that negatively affected growth in the historic period were stringent regulations for approval of pharmaceutical drugs, pricing pressures from regulators, coronavirus pandemic and high competition between API manufacturers.

Going forward, a rise in ageing population, rapid technological advancements, rising prevalence of cancer, increasing mergers and acquisitions and high potential of emerging economies will drive the growth. Factors that could hinder the growth of the pharmaceutical API manufacturing market in the future include rising popularity of alternative therapies and natural remedies, high cost of API and drug development with threat of failure and Russia-Ukraine war.

Pharmaceutical API Manufacturing Market Drivers

The key drivers of the pharmaceutical API manufacturing market include:

Rapid Technological Advancements

Rapid technological advancements are expected to drive the growth of the API manufacturing market during forecast period. Continuous technologies promise to provide a faster and more agile approach to API development and manufacture.

For example, in March 2020, Quartic.ai and Bright Path laboratories inked an agreement to jointly develop an artificial intelligence technology platform designed for continuous manufacturing of active pharmaceutical ingredients and other small-molecule drugs. The collaboration will build on Quartic.ai’s AI manufacturing expertise and Bright path labs continuous flow reactor technologies. Therefore, the rapid technological advancements is expected to drive the growth of the pharmaceutical manufacturing API market during forecast period.

Pharmaceutical API Manufacturing Market Restraints

The key restraints on the pharmaceutical API manufacturing market include:

High Cost Of API And Drug Development With Threat Of Failure

The huge costs involved in new API and drug development with a high risk of failure is expected to limit the growth of the API manufacturing market. The development of new drugs includes many stages such as drug discovery, characterization, preclinical trials, bio-analytical testing, and clinical trials.

These stages involve a lot of investment and expenditure, yet the chance of success is low. Therefore, prolonged process of development with a high risk of failure act as a restraining factor for the API manufacturing market’s growth.

Pharmaceutical API Manufacturing Market Trends

Major trends shaping the pharmaceutical API manufacturing market include:

Use Of Artificial Intelligence (AI)

Players in the API manufacturing market are deploying artificial intelligence (AI) for continuous manufacturing of critical APIs necessary for producing crucial small-molecule drugs.

Artificial Intelligence is a machine-based learning which makes use of human intelligence functionalities like reasoning and problem-solving abilities to obtain insights and provide useful information. Companies in the market are developing an AI-based technology platform for the manufacturing of APIs.

For example, in May 2020, Quartic.ai, a US-based industrial data and AI technology company and Bright Path Labs, a US-based pharmaceutical manufacturing technology company collaborated to develop an AI-based continuous manufacturing platform for the manufacturing of active pharmaceutical ingredients and other small molecule drugs using Bright Path Labs’ continuous bioreactor and the Quartic.ai smart manufacturing technology. The AI technology provided by Quartic.ai will help speed up the design, validation and approval of molecules.

Greener API Manufacturing

Companies in the API manufacturing market are focusing on continuous improvement and green chemistry to increase the sustainability of API manufacturing operations.

Players in the market are concerned about the adverse impact of their operations on the environment, which cannot be reversed. Hence, they are taking efforts for strong and sustained reduction in emissions of carbon dioxide (CO2), other greenhouse gases (GHGs) and waste streams to limit climate change and damage to the environment.

For example, in October 2021, the IQ Green Chemistry Working Group, a US-based not-for-profit organization of pharmaceutical and biotechnology companies adopted the Green Aspirational Level (GAL), originally developed by a Germany-based pharmaceutical company, Boehringer Ingelheim as a standardized green efficiency goal for API manufacturing processes. The consortium also developed a Green Scorecard to show the value-added impact of green chemistry and other improvements, including process simplification.

Opportunities And Recommendations In The Pharmaceutical API Manufacturing Market

Opportunities –The top opportunities in the pharmaceutical API manufacturing market segmented by therapy area will arise in the other therapeutics uses segment, which will gain $32,015.09 millions of global annual sales by 2026. The top opportunities in the pharmaceutical API manufacturing market segmented by API type will arise in the chemical API segment, which will gain $42,129.38 millions of global annual sales by 2026. The top opportunities in the pharmaceutical API manufacturing market segmented by drug type will arise in the prescription drugs segment, which will gain $54,890.94 millions of global annual sales by 2026. The pharmaceutical API manufacturing market size will gain the most in the USA at $18,140.25 million

Recommendations –To take advantage of the opportunities, The Business Research Company recommends the pharmaceutical API manufacturing companies to focus on greener API manufacturing, focus on artificial intelligence, focus on mergers and acquisitions, expand in emerging markets, provide competitively priced offerings, continue to participate in events and conferences, continue to use B2B promotions, focus on fast-growing therapeutic applications, focus on securing long-term supply contracts with pharmaceutical companies.

Pharmaceutical API Manufacturing Market Segmentation

The pharmaceutical API manufacturing market is segmented by therapy area, by API type and by drug type.
By Therapy Area –
The pharmaceutical API manufacturing market is segmented by therapy area into:
    • a) Cardiovascular Disorders
    • b) Metabolic Disorders
    • c) Neurological Disorders
    • d) Oncology
    • e) Musculoskeletal Disorders
    • f) Other Therapeutics Uses
The other therapeutics uses market was the largest segment of the pharmaceutical API manufacturing market segmented by therapy area, accounting for 45.57% of the total in 2021. Going forward, the oncology segment is expected to be the fastest growing segment in the pharmaceutical API manufacturing market segmented by therapy area, at a CAGR of 8.44% during 2021-2026.
By API Type –
The pharmaceutical API manufacturing market is segmented by API type into:
    • a) Chemical API
    • b) Biological API
The chemical API market was the largest segment of the pharmaceutical API manufacturing market segmented by API type, accounting for 71.89% of the total in 2021. Going forward, the biological API segment is expected to be the fastest growing segment in the pharmaceutical API manufacturing market segmented by API type, at a CAGR of 7.00% during 2021-2026
By Drug Type –
The pharmaceutical API manufacturing market is segmented by drug type into:
    • a) Prescription Drugs
    • b) Over-The-Counter (Otc) Drugs
The prescription drugs market was the largest segment of the pharmaceutical API manufacturing market segmented by drug type, accounting for 88.20% of the total in 2021. Going forward, over-the-counter (OTC) drugs segment is expected to be the fastest growing segment in the pharmaceutical API manufacturing market segmented by drug type, at a CAGR of 6.58% during 2021-2026.
By Geography- The pharmaceutical API manufacturing market is segmented by geography into
    • o Asia Pacific
      • •  China
      • •  Japan
      • •  India
      • •  Australia
      • •  Indonesia
      • •  South Korea
      • o North America
      • • USA
      o South America
      • • Brazil 
      o Western Europe
      • • UK 
      • • Germany 
      • • France 
      o Eastern Europe
      • • Russia 
      o Middle East
      o Africa
Asia Pacific was the largest region in the pharmaceutical API manufacturing market, accounting for 36.71% of the total in 2022. It was followed by North America, and then the other regions. Going forward, the fastest-growing regions in the pharmaceutical API manufacturing market will be Asia Pacific and North America where growth will be at CAGRs of 6.63% and 6.24% respectively. These will be followed by Western Europe and South America where the markets are expected to grow at CAGRs of 6.05% and 5.37% respectively.

Pharmaceutical API Manufacturing Market Competitive Landscape

Major Competitors are:

  • Pfizer Inc.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Aurobindo Pharma
  • Dr. Reddy’s Laboratories

    • Other Competitors Include:

  • BASF SE
  • Sun Pharmaceutical Industries Ltd
  • Novartis AG
  • Lupin Ltd
  • Cipla Inc.
  • Arlak Biotech
  • Healthkind Labs Pvt. Ltd
  • SwisscheM Healthcare Pvt. Ltd
  • Apikos Pharma
  • Kolaz biotech
  • CStone Pharma
  • CARsgen Therapeutics
  • JW Therapeutics
  • BeiGene
  • Takeda Pharmaceuticals
  • Astellas Pharma Inc
  • Otsuka Pharmaceutical Co, Ltd
  • Legend Biotech Co
  • Zai Lab
  • Daiichi Pharmaceutical
  • Sankyo
  • GlaxoSmithKline (GSK)
  • AstraZeneca
  • Abbott Laboratories
  • Vectura Group
  • Roche Holding AG
  • Merck & Co
  • Boehringer Ingelheim
  • Zentiva
  • Microgen
  • Geropharm
  • Valenta
  • NovaMedica
  • Veropharm
  • Celon Pharma
  • SynBio
  • Generium
  • Skopinpharm
  • ALMEDIS
  • Biocad
  • Farmacol
  • Polska Grupa Farmaceutyczna
  • Polpharma
  • Mylan
  • BioVectra
  • Celgene Corporation
  • Kashiv Pharma
  • Cambrex
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • Apotex
  • Gilead Sciences
  • AbbVie Inc
  • Hisun USA Inc
  • AMEGA Biotech
  • BioMarin pharmaceutical
  • Ferring Pharmaceuticals
  • Tikun Olam Cannbit
  • Wavelength Pharmaceuticals
  • SAUDIBIO
  • Tabuk Pharmaceuticals
  • Cipla
  • Bayer
  • Adcock Ingram
  • Johnson & Johnson
  • AstraZeneca Pharmaceutical (Pty) Ltd
  • Eurolab
  • Ranbaxy (SA) (Pty) Ltd
  • Aspen

      • Table Of Contents

      1. Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction and Market Characteristics

      6.1. General Market Definition

      6.2. Summary

      6.3. Pharmaceutical API Manufacturing Market Definition and Segmentations

      6.4. Market Segmentation By Therapy Area

      6.4.1. Cardiovascular Disorders

      6.4.2. Metabolic Disorders

      6.4.3. Neurological Disorders

      6.4.4. Oncology

      6.4.5. Musculoskeletal Disorders

      6.4.6. Other Therapeutics Uses

      6.5. Market Segmentation By API Type

      6.5.1. Chemical API

      6.5.2. Biological API

      6.6. Market Segmentation By Drug Type

      6.6.1. Prescription Drugs

      6.6.2. Over-The-Counter (OTC) Drugs

      7. Major Market Trends

      7.1. Focus On Production Facility Expansion

      7.2. Use Of Artificial Intelligence (AI)

      7.3. Greener API Manufacturing

      7.4. Increasing Investments

      7.5. QR Code Labelling

      8. Global Market Size And Growth

      8.1. Market Size

      8.2. Historic Market Growth, 2016 – 2021, Value ($ Million)

      8.2.1. Market Drivers 2016 – 2021

      8.2.2. Market Restraints 2016 – 2021

      8.3. Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      8.3.1. Market Drivers 2021 – 2026

      8.3.2. Market Restraints 2021 – 2026

      9. Global Market Segmentation

      9.1. Global Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      9.2. Global Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      9.3. Global Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      10. Global Market, Regional And Country Analysis

      10.1. Global Pharmaceutical API Manufacturing Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      10.2. Global Pharmaceutical API Manufacturing Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11. Asia-Pacific Market

      11.1. Summary

      11.2. Market Overview

      11.2.1. Region Information

      11.2.2. Market Information

      11.2.3. Background Information

      11.2.4. Government Initiatives

      11.2.5. Regulations

      11.2.6. Regulatory Bodies

      11.2.7. Major Associations

      11.2.8. Taxes Levied

      11.2.9. Corporate Tax Structure

      11.2.10. Investments

      11.2.11. Major Companies

      11.3. Asia-Pacific Pharmaceutical API Manufacturing Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.4. Asia-Pacific Pharmaceutical API Manufacturing Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.5. Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.6. Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.7. Asia Pacific Pharmaceutical API Manufacturing Market: Country Analysis

      11.8. China Market

      11.9. Summary

      11.10. Market Overview

      11.10.1. Country Information

      11.10.2. Market Information

      11.10.3. Background Information

      11.10.4. Government Initiatives

      11.10.5. Regulations

      11.10.6. Regulatory Bodies

      11.10.7. Major Associations

      11.10.8. Taxes Levied

      11.10.9. Corporate Tax Structure

      11.10.10. Investments

      11.10.11. Major Companies

      11.11. China Pharmaceutical API Manufacturing Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.12. China Pharmaceutical API Manufacturing Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.13. China Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.14. China Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.15. India Market

      11.16. India Pharmaceutical API Manufacturing Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.17. India Pharmaceutical API Manufacturing Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.18. India Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.19. India Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.20. Japan Market

      11.21. Japan Pharmaceutical API Manufacturing Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.22. Japan Pharmaceutical API Manufacturing Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.23. Japan Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.24. Japan Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.25. Australia Market

      11.26. Australia Pharmaceutical API Manufacturing Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.27. Australia Pharmaceutical API Manufacturing Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.28. Australia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.29. Australia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.30. Indonesia Market

      11.31. Indonesia Pharmaceutical API Manufacturing Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.32. Indonesia Pharmaceutical API Manufacturing Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.33. Indonesia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.34. Indonesia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.35. South Korea Market

      11.36. South Korea Pharmaceutical API Manufacturing Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.37. South Korea Pharmaceutical API Manufacturing Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.38. South Korea Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.39. South Korea Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12. Western Europe Market

      12.1. Summary

      12.2. Market Overview

      12.2.1. Region Information

      12.2.2. Market Information

      12.2.3. Background information

      12.2.4. Government Initiatives

      12.2.5. Regulations

      12.2.6. Regulatory Bodies

      12.2.7. Major Associations

      12.2.8. Taxes Levied

      12.2.9. Corporate Tax Structure

      12.2.10. Investments

      12.2.11. Major Companies

      12.3. Western Europe Pharmaceutical API Manufacturing Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      12.4. Western Europe Pharmaceutical API Manufacturing Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      12.5. Western Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.6. Western Europe Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.7. Western Europe Pharmaceutical API Manufacturing Market: Country Analysis

      12.8. UK Market

      12.9. UK Pharmaceutical API Manufacturing Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      12.10. UK Pharmaceutical API Manufacturing Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      12.11. UK Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.12. UK Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.13. Germany Market

      12.14. Germany Pharmaceutical API Manufacturing Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      12.15. Germany Pharmaceutical API Manufacturing Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      12.16. Germany Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.17. Germany Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.18. France Market

      12.19. France Pharmaceutical API Manufacturing Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      12.20. France Pharmaceutical API Manufacturing Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      12.21. France Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.22. France Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13. Eastern Europe Market

      13.1. Summary

      13.2. Market Overview

      13.2.1. Region Information

      13.2.2. Market Information

      13.2.3. Background Information

      13.2.4. Government Initiatives

      13.2.5. Regulations

      13.2.6. Regulatory Bodies

      13.2.7. Major Associations

      13.2.8. Taxes Levied

      13.2.9. Corporate Tax Structure

      13.2.10. Investments

      13.2.11. Major Companies

      13.3. Eastern Europe Pharmaceutical API Manufacturing Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.4. Eastern Europe Pharmaceutical API Manufacturing Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.5. Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.6. Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.7. Eastern Europe Pharmaceutical API Manufacturing Market: Country Analysis

      13.8. Russia Market

      13.9. Russia Pharmaceutical API Manufacturing Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.10. Russia Pharmaceutical API Manufacturing Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.11. Russia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.12. Russia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14. North America Market

      14.1. Summary

      14.2. Market Overview

      14.2.1. Region Information

      14.2.2. Market Information

      14.2.3. Background Information

      14.2.4. Government Initiatives

      14.2.5. Regulations

      14.2.6. Regulatory Bodies

      14.2.7. Major Associations

      14.2.8. Taxes Levied

      14.2.9. Corporate Tax Structure

      14.2.10. Investments

      14.2.11. Major Companies

      14.3. North America Pharmaceutical API Manufacturing Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.4. North America Pharmaceutical API Manufacturing Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.5. North America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.6. North America Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.7. North America Pharmaceutical API Manufacturing Market: Country Analysis

      14.8. USA Market

      14.9. Summary

      14.10. Market Overview

      14.10.1. Country Information

      14.10.2. Market Information

      14.10.3. Background Information

      14.10.4. Government Initiatives

      14.10.5. Regulations

      14.10.6. Regulatory Bodies

      14.10.7. Major Associations

      14.10.8. Taxes Levied

      14.10.9. Corporate Tax Structure

      14.10.10. Investments

      14.10.11. Major Companies

      14.11. USA Pharmaceutical API Manufacturing Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.12. USA Pharmaceutical API Manufacturing Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.13. USA Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.14. USA Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15. South America Market

      15.1. Summary

      15.2. Market Overview

      15.2.1. Region Information

      15.2.2. Market Information

      15.2.3. Background Information

      15.2.4. Government Initiative

      15.2.5. Regulations

      15.2.6. Regulatory Bodies

      15.2.7. Major Associations

      15.2.8. Taxes Levied

      15.2.9. Corporate Tax Structure

      15.2.10. Investments

      15.2.11. Major Companies

      15.3. South America Pharmaceutical API Manufacturing Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      15.4. South America Pharmaceutical API Manufacturing Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      15.5. South America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.6. South America Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.7. South America Pharmaceutical API Manufacturing Market: Country Analysis

      15.8. Brazil Market

      15.9. Brazil Pharmaceutical API Manufacturing Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      15.10. Brazil Pharmaceutical API Manufacturing Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      15.11. Brazil Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.12. Brazil Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16. Middle East Market

      16.1. Summary

      16.2. Market Overview

      16.2.1. Region Information

      16.2.2. Market Information

      16.2.3. Background Information

      16.2.4. Government Initiatives

      16.2.5. Regulations

      16.2.6. Regulatory Bodies

      16.2.7. Major Associations

      16.2.8. Taxes Levied

      16.2.9. Corporate Tax Structure

      16.2.10. Investments

      16.2.11. Major Companies

      16.3. Middle East Pharmaceutical API Manufacturing Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      16.4. Middle East Pharmaceutical API Manufacturing Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      16.5. Middle East Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16.6. Middle East Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17. Africa Market

      17.1. Summary

      17.2. Market Overview

      17.2.1. Region Information

      17.2.2. Market Information

      17.2.3. Background information

      17.2.4. Government Initiatives

      17.2.5. Regulations

      17.2.6. Regulatory Bodies

      17.2.7. Major Associations

      17.2.8. Taxes Levied

      17.2.9. Corporate Tax Structure

      17.2.10. Investments

      17.2.11. Major Companies

      17.3. Africa Pharmaceutical API Manufacturing Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      17.4. Africa Pharmaceutical API Manufacturing Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      17.5. Africa Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17.6. Africa Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      18. Competitive Landscape And Company Profiles

      18.1. Company Profiles

      18.2. Pfizer Inc. Company

      18.2.1. Company Overview

      18.2.2. Products And Services

      18.2.3. Business Strategy

      18.2.4. Financial Overview

      18.3. Sanofi S.A.

      18.3.1. Company Overview

      18.3.2. Products And Services

      18.3.3. Financial overview

      18.4. Teva Pharmaceuticals

      18.4.1. Company Overview

      18.4.2. Products And Services

      18.4.3. Financial Overview

      18.5. Aurobindo Pharma

      18.5.1. Company Overview

      18.5.2. Products And Services

      18.5.3. Business Strategy

      18.5.4. Financial Overview

      18.6. Dr. Reddy’s Laboratories

      18.6.1. Company Overview

      18.6.2. Products And Services

      18.6.3. Business Strategy

      18.6.4. Financial Overview

      19. Pipeline Analysis

      20. Key Mergers And Acquisitions

      20.1. Aurobindo Pharma Completes Acquisition Of 51% Stake In GLS Pharma

      20.2. Pfizer Acquired Arena Pharmaceuticals

      20.3. AstraZeneca Acquired Alexion Pharmaceuticals

      20.4. Celltrion Completed Primary Care (PC) Product Assets Acquisition Of Takeda Pharmaceuticals

      20.5. Permira Funds Acquired Cambrex Corporation

      20.6. Bristol-Myers Squibb Acquired Celgene Corporation

      20.7. Takeda Pharmaceutical Company Limited Acquired Shire Plc

      20.8. Fuji Pharma Acquired Stake In Alvotech

      21. Opportunities And Strategies

      21.1. Global Pharmaceutical API Manufacturing Market In 2026 – Countries Offering Most New Opportunities

      21.2. Global Pharmaceutical API Manufacturing Market In 2026 – Segments Offering Most New Opportunities

      21.3. Global Pharmaceutical API Manufacturing Market In 2026 – Growth Strategies

      21.3.1. Market Trend Based Strategies

      21.3.2. Competitor Strategies

      22. Pharmaceutical API Manufacturing Market, Conclusions And Recommendations

      22.1. Conclusions

      22.2. Recommendations

      22.2.1. Product

      22.2.2. Place

      22.2.3. Price

      22.2.4. Promotion

      22.2.5. People

      23. Appendix

      23.1. Market Data Sources

      23.2. Research Methodology

      23.3. Currencies

      23.4. The Business Research Company

      24. Copyright and Disclaimer

    List Of Tables

      Table 1: Global Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Table 2: Global Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 3: Global Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 4: Global Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 5: Global Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 6: Global Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 7: Global Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 8: Global Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 9: Global Pharmaceutical API Manufacturing Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 10: Global Pharmaceutical API Manufacturing Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 11: Global Pharmaceutical API Manufacturing Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 12: Global Pharmaceutical API Manufacturing Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 13: Asia-Pacific Population By Age Group, By Country, 2016-2026, Thousands
    • Table 14: Asia-Pacific GDP Per Capita, By Country, 2016-2021, $
    • Table 15: Asia-Pacific High Potency APIs Market, Pharmaceuticals Drugs Market Size, By Country, 2016-2026, $ Billion
    • Table 16: Asia-Pacific Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Table 17: Asia-Pacific Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 18: Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 19: Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 20: Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 21: Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 22: China Population By Age Group, 2016-2026, Thousands
    • Table 23: China GDP Per Capita, 2016-2021, $
    • Table 24: China High Potency APIs Market, Pharmaceuticals Drugs Market Size, 2016-2026, $ Billion
    • Table 25: China Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Table 26: China Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 27: China Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 28: China Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 29: China Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 30: China Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 31: India Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Table 32: India Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 33: India Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 34: India Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 35: India Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 36: India Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 37: Japan Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Table 38: Japan Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 39: Japan Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 40: Japan Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 41: Japan Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 42: Japan Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 43: Australia Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Table 44: Australia Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 45: Australia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 46: Australia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 47: Australia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 48: Australia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 49: Indonesia Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Table 50: Indonesia Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 51: Indonesia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 52: Indonesia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 53: Indonesia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 54: Indonesia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 55: South Korea Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Table 56: South Korea Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 57: South Korea Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 58: South Korea Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 59: South Korea Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 60: South Korea Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 61: Western Europe Population By Age Group, By Country, 2016-2026, Thousands
    • Table 62: Western Europe GDP Per Capita, By Country, 2016-2021, $
    • Table 63: Western Europe High Potency APIs Market, Pharmaceuticals Drugs Market Size, By Country, 2016-2026, $ Billion
    • Table 64: Western Smart Europe Washing Machines Market, Historic, 2016 – 2021, $ Million
    • Table 65: Western Europe Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 66: Western Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 67: Western Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 68: Western Europe Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 69: Western Europe Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 70: UK Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Table 71: UK Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 72: UK Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 73: UK Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 74: UK Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 75: UK Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 76: Germany Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Table 77: Germany Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 78: Germany Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 79: Germany Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 80: Germany Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 81: Germany Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 82: France Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Table 83: France Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 84: France Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 85: France Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 86: France Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 87: France Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 88: Eastern Europe Population By Age Group, By Country, 2016-2026, Thousands
    • Table 89: Eastern Europe GDP Per Capita, By Country, 2016-2021, $
    • Table 90: Eastern Europe High Potency APIs Market, Pharmaceuticals Drugs Market Size, By Country, 2016-2026, $ Billion
    • Table 91: Eastern Europe Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Table 92: Eastern Europe Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 93: Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 94: Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 95: Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 96: Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 97: Russia Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Table 98: Russia Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 99: Russia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 100: Russia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 101: Russia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 102: Russia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 103: North America Population By Age Group, By Country, 2016-2026, Thousands
    • Table 104: North America GDP Per Capita, By Country, 2016-2021, $
    • Table 105: North America High Potency APIs Market, Pharmaceuticals Drugs Market Size, By Country, 2016-2026, $ Billion
    • Table 106: North America Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Table 107: North America Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 108: North America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 109: North America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 110: North America Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 111: North America Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 112: USA Population By Age Group, 2016-2026, Thousands
    • Table 113: USA GDP Per Capita, 2016-2021, $
    • Table 114: USA High Potency APIs Market, Pharmaceuticals Drugs Market Size, 2016-2026, $ Billion
    • Table 115: USA Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Table 116: USA Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 117: USA Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 118: USA Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 119: USA Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 120: USA Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 121: South America Population By Age Group, By Country, 2016-2026, Thousands
    • Table 122: South America GDP Per Capita, By Country, 2016-2021, $
    • Table 123: South America High Potency APIs Market, Pharmaceuticals Drugs Market Size, By Country, 2016-2026, $ Billion
    • Table 124: South America Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Table 125: South America Washing Machines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 126: South America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 127: South America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 128: South America Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 129: South America Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 130: Brazil Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Table 131: Brazil Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 132: Brazil Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 133: Brazil Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 134: Brazil Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 135: Brazil Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 136: Middle East Population By Age Group, By Country, 2016-2026, Thousands
    • Table 137: Middle East GDP Per Capita, By Country, 2016-2021, $
    • Table 138: Middle East High Potency APIs Market, Pharmaceuticals Drugs Market Size, By Country, 2016-2026, $ Billion
    • Table 139: Middle East Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Table 140: Middle East Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 141: Middle East Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 142: Middle East Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 143: Middle East Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 144: Middle East Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 145: Africa Population By Age Group, By Country, 2016-2026, Thousands
    • Table 146: Africa GDP Per Capita, By Country, 2016-2021, $
    • Table 147: Africa High Potency APIs Market, Pharmaceuticals Drugs Market Size, By Country, 2016-2026, $ Billion
    • Table 148: Africa Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Table 149: Africa Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 150: Africa Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 151: Africa Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 152: Africa Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 153: Africa Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 154: Global Pharmaceutical API Manufacturing Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
    • Table 155: Pfizer – Financial Performance, 2017 – 2021, $ Billion
    • Table 156: Sanofi S.A.  –  Financial Performance, 2016 – 2021, $ Million
    • Table 157: Teva Pharmaceuticals – Financial Performance, 2017 – 2021, $ Billion
    • Table 158: Aurobindo Pharma – Financial Performance, 2017 – 2021, $ Billion
    • Table 159: Dr. Reddy’s Laboratories – Financial Performance, 2017 – 2021, $ Billion
    • Table 160: Global Pharmaceutical API Manufacturing Market, Pipeline Analysis
    • Table 161: Global Pharmaceutical API Manufacturing Market Size Gain ($ Million), 2021 – 2026, By Country
    • Table 162: Global Pharmaceutical API Manufacturing Market Size Gain ($ Million), Segmentation By Therapy Area, 2021 – 2026
    • Table 163: Global Pharmaceutical API Manufacturing Market Size Gain ($ Million), Segmentation By API Type, 2021 – 2026
    • Table 164: Global Pharmaceutical API Manufacturing Market Size Gain ($ Million), Segmentation By Drug Type, 2021 – 2026
    • Table 165: Pharmaceutical API Manufacturing Market Data Sources

    List Of Figures

      Figure 1: Geographic Regions Covered
    • Figure 2: Global Pharmaceutical API Manufacturing Market Segmentation By Therapy Area
    • Figure 3: Global Pharmaceutical API Manufacturing Market Segmentation By API Type
    • Figure 4: Global Pharmaceutical API Manufacturing Market Segmentation By Drug Type
    • Figure 5: Global Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Figure 6: Global Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 7: Global Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 8: Global Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 9: Global Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 10: Global Pharmaceutical API Manufacturing Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 11: Global Pharmaceutical API Manufacturing Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 12: Asia-Pacific Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Figure 13: Asia-Pacific Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 14: Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 15: Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 16: China Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Figure 17: China Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 18: China Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 19: China Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 20: India Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Figure 21: India Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 22: India Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 23: India Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 24: Japan Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Figure 25: Japan Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 26: Japan Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 27: Japan Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 28: Australia Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Figure 29: Australia Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 30: Australia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 31: Australia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 32: Indonesia Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Figure 33: Indonesia Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 34: Indonesia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 35: Indonesia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 36: South Korea Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Figure 37: South Korea Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 38: South Korea Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 39: South Korea Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 40: Western Europe Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Figure 41: Western Europe Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 42: Western Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 43: Western Europe Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 44: UK Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Figure 45: UK Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 46: UK Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 47: UK Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 48: Germany Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Figure 49: Germany Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 50: Germany Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 51: Germany Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 52: France Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Figure 53: France Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 54: France Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 55: France Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 56: Eastern Europe Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Figure 57: Eastern Europe Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 58: Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 59: Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 60: Russia Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Figure 61: Russia Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 62: Russia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 63: Russia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 64: North America Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Figure 65: North America Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 66: North America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 67: North America Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 68: USA Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Figure 69: USA Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 70: USA Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 71: USA Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 72: South America Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Figure 73: South America Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 74: South America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 75: South America Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 76: Brazil Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Figure 77: Brazil Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 78: Brazil Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 79: Brazil Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 80: Middle East Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Figure 81: Middle East Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 82: Middle East Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 83: Middle East Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 84: Africa Pharmaceutical API Manufacturing Market, Historic, 2016 – 2021, $ Million
    • Figure 85: Africa Pharmaceutical API Manufacturing Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 86: Africa Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 87: Africa Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 88: Global Pharmaceutical API Manufacturing Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
    • Figure 89: Pfizer – Financial Performance, 2017 – 2021, $ Billion
    • Figure 90: Sanofi S.A. – Financial Performance, 2016 – 2021, $ Million
    • Figure 91: Teva Pharmaceuticals – Financial Performance, 2017 – 2021 $ Billion
    • Figure 92: Aurobindo Pharma – Financial Performance, 2017 – 2021 $ Billion
    • Figure 93: Dr. Reddy’s Laboratories – Financial Performance, 2017 – 2021, $ Billion
    Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
    Read More
    Global Gene Therapy Market 2022 – Market Opportunities And Strategies
    Read More
    The Microbiome Market Share, Market Size, And Growth Rate 2022
    Read More
    Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
    Read More
    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
    Read More
    Pharmaceutical Drugs Global Market Report 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Disease Drugs, Vaccine And Therapeutic Nutrients, Minerals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter (OTC) Drugs, Prescription-Based Drugs) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Pharmaceutical Excipients Global Market Report 2024 – By Product (Inorganic Chemicals, Organic Chemicals, Other Products), By Functionality (Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavoring Agents And Sweeteners, Disintegrants, Colorants, Lubricants And Glidants, Other Functionalities), By Type Of Formulation (Oral Formulation, Topical Formulation, Parenteral Formulation, Other Formulations) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Pharmaceutical Packaging Equipment Global Market Report 2024 – By Product (Primary Packaging Equipment, Secondary Packaging Equipment, Labelling And Sterilization Equipment), By Packaging Type (Liquids Packaging Equipment, Solid Packaging Equipment, Semi-Solid Packaging Equipment), By Equipment Type (Blenders, Granulators, Tablet Pressers, Tablet Coating Machine, Allied Machines), By Mode of Administration (Injectable Administration, Topical Administration, Oral Administration) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Pharmaceutical Processing Seals Global Market Report 2024 – By Type (O-rings, Gaskets, Lip seals, D seals, Other types (Diaphragms and X-rings)), By Material (Metals, PTFE, Silicone, Nitrile Rubber, EPDM, Other materials), By Application (Manufacturing Equipment, Agitators, Mixers, Reactors, Gear Boxes, Other applications) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Pharmaceutical Drug Delivery Global Market Report 2024 – By Route of Administration (Oral, Ocular, Pulmonary, Nasal, Injectable, Topical, Other Routes), By Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Autoimmune Diseases, Other Applications), By End-User (Hospitals, Home Care Settings, ASC/Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Pharmaceutical Sterility Testing Global Market Report 2024 – By Sample (Sterile Drugs, Medical Devices, Biologics and Therapeutics), By Product Type (Instruments, Kits and Reagents, Services), By Type (In- house, Outsourcing), By Test Type (Sterility Testing, Bioburden Testing, Bacterial Endotoxin Testing), By End- User (Compounding Pharmacies, Medical Devices Companies, Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2024-2033
    View Report